Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zidovudine 100mg capsules
0503010Y0AAAAAA
|
Zidovudine | Zidovudine | Infections | 1 |
|
Zidovudine 250mg capsules
0503010Y0AAABAB
|
Zidovudine | Zidovudine | Infections | 1 |
|
Retrovir 100mg capsules
0503010Y0BBAAAA
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir 100mg/10ml oral solution
0503010Y0BBAEAD
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir 250mg capsules
0503010Y0BBABAB
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir IV 200mg/20ml concentrate for inf vials
0503010Y0BBAFAE
|
Retrovir | Zidovudine | Infections | No data available |
|
Zidovudine 10mg/1ml oral solution sugar free
0503010Y0AAADAD
|
Zidovudine | Zidovudine | Infections | No data available |
|
Zidovudine 200mg/20ml solution for infusion vials
0503010Y0AAAEAE
|
Zidovudine | Zidovudine | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.